Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
Clinical trial NCT00066352 · COMPLETED
Trial details
- NCT number
- NCT00066352
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2003-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.